Search Results 471-480 of 18302 for Hepatitis b

  1. Transmission Of Hepatitis C Infection To Patients - Mayo Clinic News Network

    An extensive investigation into hepatitis C infections in three transplant patients led investigators to uncover the route of transmission.

  2. Afamitresgene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Infections (eg, hepatitis B), active or history of or; Kidney disease or; Lung or breathing problems or; Seizures, history of or; Stroke, history of—Use with ...

  3. Pasireotide LAR in Severe Polycystic Liver Disease - Mayo Clinic

    Patients with a known history of hepatitis B or C; Presence of Hepatitis B surface antigen (HbsAg); Presence of Hepatitis C antibody (anti-HCV); Patients with ...

  4. 5-05-2022 Media Only News Briefing: Hepatitis in children: What parents need to know

    A sudden increase in the number of children experiencing severe hepatitis has caught the attention of national health experts.

  5. Marginal zone lymphoma - Symptoms and causes - Mayo Clinic

    These cells are called B cells, also known as B lymphocytes. In MZL, changes ... pylori, hepatitis C, Chlamydophila psittaci, Campylobacter jejuni and Borrelia ...

  6. GEN3013, Epcoritamab Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma EPCORE™ NHL-1 - Mayo Clinic

    Active hepatitis B or hepatitis C. If laboratory evidence for a chronic infection with hepatitis B close monitoring and prophylactic therapy is required.

  7. Clinical Trials - AUTO1 in Relapsed or Refractory B-ALL

    ... B-Cell Acute Lymphoblastic Leukaemia (r/r B-ALL). Participation eligibility ... Active or latent Hepatitis B virus or active Hepatitis C virus. Human ...

  8. Publications - Imad Absah, M.D. - Mayo Clinic

    Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease. Clin Gastroenterol Hepatol. 2023 Oct; 21(11):2901-2907.e2 ...

  9. Ribavirin (oral route) - Mayo Clinic

    Ribavirin is used in combination with injectable interferon alfa-2b, peginterferon alfa-2a, or peginterferon alfa-2b to treat chronic hepatitis C infection.

  10. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    those who are hepatitis B surface antigen positive or hepatitis B PCR positive and those who are hepatitis C PCR positive will be excluded - History of ...